Eli Lilly (LLY) Long-Term Debt Issuances (2016 - 2025)
Historic Long-Term Debt Issuances for Eli Lilly (LLY) over the last 12 years, with Q4 2025 value amounting to -$200000.0.
- Eli Lilly's Long-Term Debt Issuances fell 10000.0% to -$200000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $13.2 billion, marking a year-over-year increase of 1532.8%. This contributed to the annual value of $13.2 billion for FY2025, which is 1532.8% up from last year.
- According to the latest figures from Q4 2025, Eli Lilly's Long-Term Debt Issuances is -$200000.0, which was down 10000.0% from $6.7 billion recorded in Q3 2025.
- In the past 5 years, Eli Lilly's Long-Term Debt Issuances registered a high of $6.7 billion during Q3 2025, and its lowest value of -$200000.0 during Q4 2025.
- In the last 4 years, Eli Lilly's Long-Term Debt Issuances had a median value of $4.0 billion in 2023 and averaged $3.4 billion.
- Per our database at Business Quant, Eli Lilly's Long-Term Debt Issuances soared by 12453.2% in 2021 and then tumbled by 12000.0% in 2024.
- Quarter analysis of 4 years shows Eli Lilly's Long-Term Debt Issuances stood at $2.4 billion in 2021, then tumbled by 99.98% to $500000.0 in 2023, then tumbled by 120.0% to -$100000.0 in 2024, then crashed by 100.0% to -$200000.0 in 2025.
- Its Long-Term Debt Issuances was -$200000.0 in Q4 2025, compared to $6.7 billion in Q3 2025 and $6.5 billion in Q1 2025.